l-Glutamine and Whole Protein Restore First-Phase Insulin Response and Increase Glucagon-Like Peptide-1 in Type 2 Diabetes Patients

l-glutamine triggers glucagon-like peptide-1 (GLP-1) release from L cells in vitro and when ingested pre-meal, decreases postprandial glycaemia and increases circulating insulin and GLP-1 in type 2 diabetes (T2D) patients. We aimed to evaluate the effect of oral l-glutamine, compared with whole prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Samocha-Bonet, Dorit, Chisholm, Don J., Holst, Jens J., Greenfield, Jerry R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425133/
https://www.ncbi.nlm.nih.gov/pubmed/25811109
http://dx.doi.org/10.3390/nu7042101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425133/
https://www.ncbi.nlm.nih.gov/pubmed/25811109
http://dx.doi.org/10.3390/nu7042101

Ejemplares similares